Delivery Order SPE2DR25D1053-SPE2DR26FV543
- Not listed
- The Defense Logistics Agency awarded a $13,806.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Afinitor 10 mg tablets (28-unit dose packages) with an ultimate completion date of January 26, 2026. This non-set-aside contract was competitively awarded on January 2, 2026, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 28 units of Afinitor 5 mg tablets in unit dose packaging, valued at $37,057.56 under a firm fixed price contract type. The award, issued on October 27, 2025, is scheduled for completion by November 18, 2025, with performance taking place at AmerisourceBergen's headquarters in Conshohocken, Pennsylvania. This is a competitively awarded non-set-aside contract, reflecting the company's established capability to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Afinitor 10 mg tablets in unit dose packaging (28 count) with a ceiling value of $12,360.81. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 10, 2025, and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Afinitor Disperz 3 mg tablets in quantities of 28 units. This competitively awarded, non-set-aside contract carries a ceiling value of $47,663.84 under firm fixed pricing terms, with an ultimate completion date of September 8, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a delivery order valued at $13,806.98 to AmerisourceBergen Drug Corp for 28 units of Afinitor 10 mg tablets in unit-dose packaging. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of February 2, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems. The place of performance...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Afinitor Disperz 3 mg tablets in quantities of 28 count, with a ceiling value of $47,663.84 and an ultimate completion date of June 23, 2025. This non-set-aside, competitively awarded contract employs firm fixed price terms and represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with the Defense Logistics...
- This federal contract award, valued at $23,831.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Afinitor Disperz 3 mg tablets, a medication used in the treatment of various medical conditions. The contract is not designated as a set-aside and is therefore open to competition. It has an ultimate completion date of April 28, 2025....
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply Afinitor Disperz 3 mg tablets. The $10,172.07 award has a completion date of January 25, 2024. Amerisourcebergen Drug Corp is a prime contractor that has received numerous awards from DLA Troop Support Medical to provide pharmaceuticals and medical supplies in support of military treatment programs and facilities. No...
- This is a $12,352.52 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of AFINITOR 5 MG TABLET UD 28S, a prescription medication, with a period of performance through June 2025. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a wide range of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of AFINITOR DISPERZ 3 MG TABLET 28S. The contract has an ultimate completion date of April 10, 2024 and a ceiling value of $20,344.14. This delivery order is issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 through December 31, 2025....
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FV543Delivery Order
The Defense Logistics Agency awarded a $27,745.66 firm fixed-price delivery order to AmerSourceBergen Drug Corp for 28 tablets of Afinitor Dispersz 5 mg, with an ultimate completion date of February 5, 2026. This is a non-set-aside award issued competitively to the prime contractor, whose corporate office is located in Conshohocken, Pennsylvania. The awardee operates as a child entity under parent company Cencora, Inc. (doing business as AmerSourceBergen), a major pharmaceutical distributor providing critical medical supplies to federal government healthcare systems. This delivery order is executed under AmerSourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. This comprehensive global pharmaceutical support vehicle enables the contractor to supply a wide range of pharmaceutical products and medical commodities to support military healthcare programs worldwide, including medications across multiple therapeutic domains, vaccines, medical devices, and specialized supplies. The current order for Afinitor Dispersz represents a routine execution of this master contract vehicle supporting federal medical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.7k | 1/13/26 |